Skip to content

Progression of brain changes in glaucoma

Progression of brain changes in glaucoma - Progression of brain changes in glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44235
Enrollment
84
Registered
2017-07-14
Start date
2017-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma POAG

Interventions

Glaucoma
Neurodegeneration

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - To have participated in one of the relevant past cross-sectional studies conducted in our lab. - Signed informed consent.

Exclusion criteria

Exclusion criteria: For all subjects: - Development of ophthalmological or neurological disorders which affect the retina, optic nerve or the brain since the last study - Refusal to be informed in the event of discovering a brain abnormality in the brain scans - Use of recreational drugs or medications which may influence neurodegenerative progression - General contraindications of MRI (including MR-incompatible implants and tattoos, and claustrophobia) Only for controls: - Visual acuity lower than 0.8

Design outcomes

Primary

MeasureTime frame
For T1-weighted MRI scan: GM volume, WM volume, cortical thickness, cortical surface area, and mean curvature. For Diffusion-weighted MRI scan: Fractional anisotropy (FA) and mean diffusivity (MD).

Secondary

MeasureTime frame
Difference in primary parameters between follow-ups. Time interval between follow-ups.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)